 | • レポートコード：MRC2-11QY02613 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は抗ウイルス薬のグローバル市場について調査・分析したレポートです。種類別（逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系モジュレーター）市場規模、用途別（肝炎治療薬、HIV / AIDS治療薬、ヘルペス治療薬、インフルエンザ治療薬）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別抗ウイルス薬の競争状況、市場シェア ・世界の抗ウイルス薬市場：種類別市場規模 2015年-2020年（逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系モジュレーター） ・世界の抗ウイルス薬市場：種類別市場規模予測 2021年-2026年（逆転写酵素阻害剤、プロテアーゼ阻害剤、融合阻害剤、免疫系モジュレーター） ・世界の抗ウイルス薬市場：用途別市場規模 2015年-2020年（肝炎治療薬、HIV / AIDS治療薬、ヘルペス治療薬、インフルエンザ治療薬） ・世界の抗ウイルス薬市場：用途別市場規模予測 2021年-2026年（肝炎治療薬、HIV / AIDS治療薬、ヘルペス治療薬、インフルエンザ治療薬） ・北米の抗ウイルス薬市場分析：米国、カナダ ・ヨーロッパの抗ウイルス薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの抗ウイルス薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の抗ウイルス薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの抗ウイルス薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Johnson & Johnson、Merck、Novartis、Bristol-Myers Squibb、Gilead Sciences、GlaxoSmithKline、AbbVie ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Antiviral drugs are medicines that decrease the ability of flu viruses to reproduce. when used as directed, antiviral drugs may help reduce the duration of flu.
In this market study, analysts have estimated the reverse transcriptase inhibitors to dominate the antiviral drugs market during the forecast period. These are compounds that are used to inhibit the reverse transcriptase enzyme. The capability of this enzyme to catalyze the process of conversion of viral RNA into DNA, to infect the healthy host cell and replicate it is the key contributor to the growth of this segment in the hiv treatment drugs market.
Market Analysis and Insights: Global Antiviral Drugs Market
The global Antiviral Drugs market size is projected to reach US$ 42330 million by 2026, from US$ 40870 million in 2020, at a CAGR of 3.3%% during 2021-2026.
Global Antiviral Drugs Scope and Market Size
Antiviral Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antiviral Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Antiviral Drugs market is segmented into
Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators
Segment by Application, the Antiviral Drugs market is segmented into
Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics
Regional and Country-level Analysis
The Antiviral Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Antiviral Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Antiviral Drugs Market Share Analysis
Antiviral Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antiviral Drugs business, the date to enter into the Antiviral Drugs market, Antiviral Drugs product introduction, recent developments, etc.
The major vendors covered:
Roche
Johnson & Johnson
Merck
Novartis
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
AbbVie
1 Study Coverage
1.1 Antiviral Drugs Product Introduction
1.2 Market Segments
1.3 Key Antiviral Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Antiviral Drugs Market Size Growth Rate by Type
1.4.2 Reverse Transcriptase Inhibitors
1.4.3 Protease Inhibitors
1.4.4 Fusion Inhibitors
1.4.5 Immune System Modulators
1.5 Market by Application
1.5.1 Global Antiviral Drugs Market Size Growth Rate by Application
1.5.2 Hepatitis Therapeutics
1.5.3 HIV/AIDS Therapeutics
1.5.4 Herpes Therapeutics
1.5.5 Influenza Therapeutics
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antiviral Drugs Market Size, Estimates and Forecasts
2.1.1 Global Antiviral Drugs Revenue 2015-2026
2.1.2 Global Antiviral Drugs Sales 2015-2026
2.2 Global Antiviral Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Antiviral Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Antiviral Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Antiviral Drugs Competitor Landscape by Players
3.1 Antiviral Drugs Sales by Manufacturers
3.1.1 Antiviral Drugs Sales by Manufacturers (2015-2020)
3.1.2 Antiviral Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Antiviral Drugs Revenue by Manufacturers
3.2.1 Antiviral Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Antiviral Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Antiviral Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Antiviral Drugs Revenue in 2019
3.2.5 Global Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Antiviral Drugs Price by Manufacturers
3.4 Antiviral Drugs Manufacturing Base Distribution, Product Types
3.4.1 Antiviral Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antiviral Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Antiviral Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Antiviral Drugs Market Size by Type (2015-2020)
4.1.1 Global Antiviral Drugs Sales by Type (2015-2020)
4.1.2 Global Antiviral Drugs Revenue by Type (2015-2020)
4.1.3 Antiviral Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Antiviral Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Antiviral Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Antiviral Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Antiviral Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Antiviral Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Antiviral Drugs Market Size by Application (2015-2020)
5.1.1 Global Antiviral Drugs Sales by Application (2015-2020)
5.1.2 Global Antiviral Drugs Revenue by Application (2015-2020)
5.1.3 Antiviral Drugs Price by Application (2015-2020)
5.2 Antiviral Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Antiviral Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Antiviral Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Antiviral Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Antiviral Drugs by Country
6.1.1 North America Antiviral Drugs Sales by Country
6.1.2 North America Antiviral Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Antiviral Drugs Market Facts & Figures by Type
6.3 North America Antiviral Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Antiviral Drugs by Country
7.1.1 Europe Antiviral Drugs Sales by Country
7.1.2 Europe Antiviral Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antiviral Drugs Market Facts & Figures by Type
7.3 Europe Antiviral Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Antiviral Drugs by Region
8.1.1 Asia Pacific Antiviral Drugs Sales by Region
8.1.2 Asia Pacific Antiviral Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Antiviral Drugs Market Facts & Figures by Type
8.3 Asia Pacific Antiviral Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Antiviral Drugs by Country
9.1.1 Latin America Antiviral Drugs Sales by Country
9.1.2 Latin America Antiviral Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Antiviral Drugs Market Facts & Figures by Type
9.3 Central & South America Antiviral Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Antiviral Drugs by Country
10.1.1 Middle East and Africa Antiviral Drugs Sales by Country
10.1.2 Middle East and Africa Antiviral Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Antiviral Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Antiviral Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Antiviral Drugs Products Offered
11.1.5 Roche Related Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Description and Business Overview
11.2.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Johnson & Johnson Antiviral Drugs Products Offered
11.2.5 Johnson & Johnson Related Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Description and Business Overview
11.3.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck Antiviral Drugs Products Offered
11.3.5 Merck Related Developments
11.4 Novartis
11.4.1 Novartis Corporation Information
11.4.2 Novartis Description and Business Overview
11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis Antiviral Drugs Products Offered
11.4.5 Novartis Related Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Corporation Information
11.5.2 Bristol-Myers Squibb Description and Business Overview
11.5.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Bristol-Myers Squibb Antiviral Drugs Products Offered
11.5.5 Bristol-Myers Squibb Related Developments
11.6 Gilead Sciences
11.6.1 Gilead Sciences Corporation Information
11.6.2 Gilead Sciences Description and Business Overview
11.6.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Gilead Sciences Antiviral Drugs Products Offered
11.6.5 Gilead Sciences Related Developments
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Corporation Information
11.7.2 GlaxoSmithKline Description and Business Overview
11.7.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GlaxoSmithKline Antiviral Drugs Products Offered
11.7.5 GlaxoSmithKline Related Developments
11.8 AbbVie
11.8.1 AbbVie Corporation Information
11.8.2 AbbVie Description and Business Overview
11.8.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AbbVie Antiviral Drugs Products Offered
11.8.5 AbbVie Related Developments
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Description and Business Overview
11.1.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Roche Antiviral Drugs Products Offered
11.1.5 Roche Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Antiviral Drugs Market Estimates and Projections by Region
12.1.1 Global Antiviral Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Antiviral Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Antiviral Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Antiviral Drugs Sales Forecast (2021-2026)
12.2.2 North America: Antiviral Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Antiviral Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Antiviral Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Antiviral Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Antiviral Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Antiviral Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Antiviral Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Antiviral Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Antiviral Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Antiviral Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Antiviral Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Antiviral Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Antiviral Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Antiviral Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Antiviral Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Antiviral Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Antiviral Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Antiviral Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Antiviral Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antiviral Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Antiviral Drugs Market Segments
Table 2. Ranking of Global Top Antiviral Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Antiviral Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Reverse Transcriptase Inhibitors
Table 5. Major Manufacturers of Protease Inhibitors
Table 6. Major Manufacturers of Fusion Inhibitors
Table 7. Major Manufacturers of Immune System Modulators
Table 8. Global Antiviral Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Antiviral Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Antiviral Drugs Sales by Regions 2015-2020 (K Units)
Table 11. Global Antiviral Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Antiviral Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Antiviral Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Antiviral Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Antiviral Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Antiviral Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antiviral Drugs as of 2019)
Table 17. Antiviral Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Antiviral Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Antiviral Drugs Price (2015-2020) (USD/Unit)
Table 20. Antiviral Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Antiviral Drugs Product Type
Table 22. Date of International Manufacturers Enter into Antiviral Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Antiviral Drugs Sales by Type (2015-2020) (K Units)
Table 25. Global Antiviral Drugs Sales Share by Type (2015-2020)
Table 26. Global Antiviral Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Antiviral Drugs Revenue Share by Type (2015-2020)
Table 28. Antiviral Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Antiviral Drugs Sales by Application (2015-2020) (K Units)
Table 30. Global Antiviral Drugs Sales Share by Application (2015-2020)
Table 31. North America Antiviral Drugs Sales by Country (2015-2020) (K Units)
Table 32. North America Antiviral Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Antiviral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Antiviral Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Antiviral Drugs Sales by Type (2015-2020) (K Units)
Table 36. North America Antiviral Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Antiviral Drugs Sales by Application (2015-2020) (K Units)
Table 38. North America Antiviral Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Antiviral Drugs Sales by Country (2015-2020) (K Units)
Table 40. Europe Antiviral Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Antiviral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Antiviral Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Antiviral Drugs Sales by Type (2015-2020) (K Units)
Table 44. Europe Antiviral Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Antiviral Drugs Sales by Application (2015-2020) (K Units)
Table 46. Europe Antiviral Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Antiviral Drugs Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific Antiviral Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Antiviral Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Antiviral Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Antiviral Drugs Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific Antiviral Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Antiviral Drugs Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific Antiviral Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Antiviral Drugs Sales by Country (2015-2020) (K Units)
Table 56. Latin America Antiviral Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Antiviral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Antiviral Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Antiviral Drugs Sales by Type (2015-2020) (K Units)
Table 60. Latin America Antiviral Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Antiviral Drugs Sales by Application (2015-2020) (K Units)
Table 62. Latin America Antiviral Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Antiviral Drugs Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa Antiviral Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Antiviral Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Antiviral Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Antiviral Drugs Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa Antiviral Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Antiviral Drugs Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa Antiviral Drugs Sales Market Share by Application (2015-2020)
Table 71. Roche Corporation Information
Table 72. Roche Description and Major Businesses
Table 73. Roche Antiviral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Roche Product
Table 75. Roche Recent Development
Table 76. Johnson & Johnson Corporation Information
Table 77. Johnson & Johnson Description and Major Businesses
Table 78. Johnson & Johnson Antiviral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Johnson & Johnson Product
Table 80. Johnson & Johnson Recent Development
Table 81. Merck Corporation Information
Table 82. Merck Description and Major Businesses
Table 83. Merck Antiviral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Merck Product
Table 85. Merck Recent Development
Table 86. Novartis Corporation Information
Table 87. Novartis Description and Major Businesses
Table 88. Novartis Antiviral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Novartis Product
Table 90. Novartis Recent Development
Table 91. Bristol-Myers Squibb Corporation Information
Table 92. Bristol-Myers Squibb Description and Major Businesses
Table 93. Bristol-Myers Squibb Antiviral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Bristol-Myers Squibb Product
Table 95. Bristol-Myers Squibb Recent Development
Table 96. Gilead Sciences Corporation Information
Table 97. Gilead Sciences Description and Major Businesses
Table 98. Gilead Sciences Antiviral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Gilead Sciences Product
Table 100. Gilead Sciences Recent Development
Table 101. GlaxoSmithKline Corporation Information
Table 102. GlaxoSmithKline Description and Major Businesses
Table 103. GlaxoSmithKline Antiviral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. GlaxoSmithKline Product
Table 105. GlaxoSmithKline Recent Development
Table 106. AbbVie Corporation Information
Table 107. AbbVie Description and Major Businesses
Table 108. AbbVie Antiviral Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. AbbVie Product
Table 110. AbbVie Recent Development
Table 111. Global Antiviral Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 112. Global Antiviral Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 113. Global Antiviral Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 114. Global Antiviral Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 115. North America: Antiviral Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 116. North America: Antiviral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Europe: Antiviral Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 118. Europe: Antiviral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Asia Pacific: Antiviral Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 120. Asia Pacific: Antiviral Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 121. Latin America: Antiviral Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 122. Latin America: Antiviral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Middle East and Africa: Antiviral Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 124. Middle East and Africa: Antiviral Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Main Points Interviewed from Key Antiviral Drugs Players
Table 129. Antiviral Drugs Customers List
Table 130. Antiviral Drugs Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiviral Drugs Product Picture
Figure 2. Global Antiviral Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Reverse Transcriptase Inhibitors Product Picture
Figure 4. Protease Inhibitors Product Picture
Figure 5. Fusion Inhibitors Product Picture
Figure 6. Immune System Modulators Product Picture
Figure 7. Global Antiviral Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Hepatitis Therapeutics
Figure 9. HIV/AIDS Therapeutics
Figure 10. Herpes Therapeutics
Figure 11. Influenza Therapeutics
Figure 12. Antiviral Drugs Report Years Considered
Figure 13. Global Antiviral Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Antiviral Drugs Sales 2015-2026 (K Units)
Figure 15. Global Antiviral Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Antiviral Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Antiviral Drugs Sales Market Share by Region in 2019
Figure 18. Global Antiviral Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Antiviral Drugs Revenue Market Share by Region in 2019
Figure 20. Global Antiviral Drugs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Antiviral Drugs Revenue in 2019
Figure 22. Antiviral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Antiviral Drugs Sales Market Share by Type (2015-2020)
Figure 24. Global Antiviral Drugs Sales Market Share by Type in 2019
Figure 25. Global Antiviral Drugs Revenue Market Share by Type (2015-2020)
Figure 26. Global Antiviral Drugs Revenue Market Share by Type in 2019
Figure 27. Global Antiviral Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Antiviral Drugs Sales Market Share by Application (2015-2020)
Figure 29. Global Antiviral Drugs Sales Market Share by Application in 2019
Figure 30. Global Antiviral Drugs Revenue Market Share by Application (2015-2020)
Figure 31. Global Antiviral Drugs Revenue Market Share by Application in 2019
Figure 32. North America Antiviral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Antiviral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Antiviral Drugs Sales Market Share by Country in 2019
Figure 35. North America Antiviral Drugs Revenue Market Share by Country in 2019
Figure 36. U.S. Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Antiviral Drugs Market Share by Type in 2019
Figure 41. North America Antiviral Drugs Market Share by Application in 2019
Figure 42. Europe Antiviral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Antiviral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Antiviral Drugs Sales Market Share by Country in 2019
Figure 45. Europe Antiviral Drugs Revenue Market Share by Country in 2019
Figure 46. Germany Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Antiviral Drugs Market Share by Type in 2019
Figure 57. Europe Antiviral Drugs Market Share by Application in 2019
Figure 58. Asia Pacific Antiviral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Antiviral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Antiviral Drugs Sales Market Share by Region in 2019
Figure 61. Asia Pacific Antiviral Drugs Revenue Market Share by Region in 2019
Figure 62. China Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Antiviral Drugs Market Share by Type in 2019
Figure 85. Asia Pacific Antiviral Drugs Market Share by Application in 2019
Figure 86. Latin America Antiviral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Antiviral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Antiviral Drugs Sales Market Share by Country in 2019
Figure 89. Latin America Antiviral Drugs Revenue Market Share by Country in 2019
Figure 90. Mexico Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Antiviral Drugs Market Share by Type in 2019
Figure 97. Latin America Antiviral Drugs Market Share by Application in 2019
Figure 98. Middle East and Africa Antiviral Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Antiviral Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Antiviral Drugs Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Antiviral Drugs Revenue Market Share by Country in 2019
Figure 102. Turkey Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Antiviral Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Antiviral Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Antiviral Drugs Market Share by Type in 2019
Figure 109. Middle East and Africa Antiviral Drugs Market Share by Application in 2019
Figure 110. North America Antiviral Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Antiviral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Antiviral Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Antiviral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Antiviral Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Antiviral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Antiviral Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Antiviral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Antiviral Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Antiviral Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
C型肝炎ウイルス（HCV）抗ウイルス剤の世界市場（～2026年） Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatit…- 頭頸部がん治療薬/治療の世界市場（～2026年） Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…
- HIV薬の世界市場（～2026年） HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population. One…
- 抗レトロウイルス薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-Retroviral Drugs Market The global Anti-Retroviral Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti-Retroviral Drugs Scope and Market Size Anti-Retroviral Drugs marke…
- C型肝炎治療薬の世界市場（～2026年） Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay colored stools etc. Hepatitis is caused by a variety of factors both microbial and non-microbial. However hepa…